MedTrace Logo

Etoricoxib as a Pre-emptive Analgesic in Therapeutic Arthroscopy

NCT00738608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2009-09-18

No results posted yet for this study

Summary

The aim of this study is to demonstrate that compared to placebo the preoperative administration of a single dose of 120 mg etoricoxib can provide adequate pain relief in the postoperative phase while reducing the need for systemic opioids. The primary endpoint is the decrease of systemic opioid use.

Conditions

Sponsors & Collaborators

  • Marienkrankenhaus Soest

    lead OTHER

Principal Investigators

  • Peter Lierz, MD · Marienkrankenhaus Soest

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2009-08-31
Completion
2009-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00738608 on ClinicalTrials.gov